GGO Vergunningendatabase

IM-MV 16-011_000 Universitair Medisch Centrum Utrecht TEG001 - T cells retrovirally engineered to express a defined γδT cell receptor (γδTCR) (clone5) 08-11-2017 Vergunning verleend
IM-MV 17-002_000 VU medisch centrum Evaluation following the administration of autologous T cells genetically modified with a retroviral vector to express Chimeric Antigen Receptors (CAR) in subject with malignant diseases Ontwerpbesluit genomen
IM-MV 17-004_000 Het Nederlands Kanker Instituut A Phase I/II Open Label Clinical Trial Assessing Safety and Efficacy of Intravesical Instillation of the Recombinant BCG VPM1002BC in Patients with Recurrent Non-Muscle Invasive Bladder Cancer after Standard BCG Therapy Ontwerpbesluit genomen